Vascular smooth muscle cells: isolation, culture, and characterization.

Department of Systems Biology and Translational Medicine, Texas A&M Health Science Center, College of Medicine, College Station, TX, USA.
Methods in molecular biology (Clifton, N.J.) (Impact Factor: 1.29). 01/2012; 843:169-76. DOI: 10.1007/978-1-61779-523-7_16
Source: PubMed

ABSTRACT Vascular smooth muscle cells (VSMCs) are the cellular components of the normal blood vessel wall that provides structural integrity and regulates the diameter by contracting and relaxing dynamically in response to vasoactive stimuli. The differentiated state of the VSMC is characterized by specific contractile proteins, ion channels, and cell surface receptors that regulate the contractile process and are thus termed contractile cells. In addition to these normal functions, in response to injury or during development, VSMCs are responsible for the synthesis of extracellular matrix proteins, become migratory and proliferate. This phenotype has been termed synthetic cells. To better understand the mechanisms regulating these and other processes, scientists have depended on cultured cells that can be manipulated in vitro. In this chapter, we will discuss in detail the explant method for isolation of VSMC and will compare it to the enzymatic digestion method. We will also briefly describe methods for characterizing the resulting cells.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Differentiation of resident multipotent vascular stem cells (MVSCs) or de-differentiation of vascular smooth muscle cells (vSMCs) might be responsible for the SMC phenotype that plays a major role in vascular diseases such as arteriosclerosis and restenosis. We examined vSMCs from three different species (rat, murine and bovine) to establish whether they exhibit neural stem cell characteristics typical of MVSCs. We determined their SMC differentiation, neural stem cell marker expression and multipotency following induction in vitro by using immunocytochemistry, confocal microscopy, fluorescence-activated cell sorting analysis and quantitative real-time polymerase chain reaction. MVSCs isolated from rat aortic explants, enzymatically dispersed rat SMCs and rat bone-marrow-derived mesenchymal stem cells served as controls. Murine carotid artery lysates and primary rat aortic vSMCs were both myosin-heavy-chain-positive but weakly expressed the neural crest stem cell marker, Sox10. Each vSMC line examined expressed SMC differentiation markers (smooth muscle α-actin, myosin heavy chain and calponin), neural crest stem cell markers (Sox10(+), Sox17(+)) and a glia marker (S100β(+)). Serum deprivation significantly increased calponin and myosin heavy chain expression and decreased stem cell marker expression, when compared with serum-rich conditions. vSMCs did not differentiate to adipocytes or osteoblasts following adipogenic or osteogenic inductive stimulation, respectively, or respond to transforming growth factor-β1 or Notch following γ-secretase inhibition. Thus, vascular SMCs in culture express neural stem cell markers typical of MVSCs, concomitant with SMC differentiation markers, but do not retain their multipotency. The ultimate origin of these cells might have important implications for their use in investigations of vascular proliferative disease in vitro.
    Cell and Tissue Research 07/2014; 358(1). DOI:10.1007/s00441-014-1937-2 · 3.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nature's inspiration is a promising tool to design new biomaterials especially for frontier technological areas such as tissue engineering and nanomedicine. Polyurethanes (PURs) are a flexible platform of materials that can be designed to fit the requirements imposed by their final applications. The choice of their building blocks (which are used in the synthesis as macrodiols, diisocyanates, and chain extenders) can be implemented to obtain biomimetic constructs, which can mimic the native tissue in terms of mechanical, morphological and surface properties. In bone tissue engineering, elastomeric PURs avoid shear forces at the interface between bone and the implant, supporting the proliferation of osteogenic cells. Soft tissues can be engineered equally efficiently by PURs, which have been reported to be reliable candidates in the fabrication of muscle constructs (including heart, blood vessels, cartilage and peripheral nerve regeneration). This review summarizes the recent progress in the biomedical applications of polyurethanes. After introducing the concept of biomimetics (paragraph 2), the use of PURs in the engineering of hard tissues (para. 3.1), soft tissues (para. 3.2) and in nanomedicine (para. 4) is reported. Taken collectively, reports in the literature clearly indicate the potential of PURs to complement or substitute alternative, FDA approved, degradable polymers, such as those belonging to the polyester family, in the replacement of damaged tissues or organs, as well as in the emerging field of nanomedicine, where they might show superior drug encapsulation efficiency and enhanced capability to target specific tissue compartments.
    07/2014; 2(32). DOI:10.1039/C4TB00525B
  • [Show abstract] [Hide abstract]
    ABSTRACT: Schisandra chinensis fruit extract (SCE) has traditionally been used as an oriental medicine for the treatment of various human diseases, including cardiovascular disease. Advances in scientific knowledge and analytical technologies provide opportunities for translational research involving S. chinensis; such research may contribute to future drug discovery. To date, emerging experimental evidence supports the therapeutic effects of the SCE or its bioactive lignan ingredients in cardiovascular disease, unraveling the mechanistic basis for their pharmacological actions. In the present review, we highlight SCE and its lignans as promising resources for the development of safe, effective, and multi-targeted agents against cardiovascular disease. Moreover, we offer novel insight into future challenges and perspective on S. chinensis research to future clinical investigations and healthcare strategies.
    Fitoterapia 06/2014; 97. DOI:10.1016/j.fitote.2014.06.014 · 2.22 Impact Factor


Available from
Jul 29, 2014